| Prevention of dietary-fat-fueled ketogenesis attenuates BRAF V600E tumor growth S Xia, R Lin, L Jin, L Zhao, HB Kang, Y Pan, S Liu, G Qian, Z Qian, ... Cell metabolism 25 (2), 358-373, 2017 | 160 | 2017 |
| Aflatoxin B1 modulates the expression of phenotypic markers and cytokines by splenic lymphocytes of male F344 rats G Qian, L Tang, X Guo, F Wang, ME Massey, J Su, TL Guo, JH Williams, ... Journal of Applied Toxicology 34 (3), 241-249, 2014 | 126 | 2014 |
| Overcoming acquired resistance to AZD9291, a third-generation EGFR inhibitor, through modulation of MEK/ERK-dependent Bim and Mcl-1 degradation P Shi, YT Oh, L Deng, G Zhang, G Qian, S Zhang, H Ren, G Wu, ... Clinical Cancer Research 23 (21), 6567-6579, 2017 | 121 | 2017 |
| Mitigation of oxidative damage by green tea polyphenols and Tai Chi exercise in postmenopausal women with osteopenia G Qian, K Xue, L Tang, F Wang, X Song, MC Chyu, BC Pence, CL Shen, ... PloS one 7 (10), e48090, 2012 | 74 | 2012 |
| Inhibition of mTOR complex 1/p70 S6 kinase signaling elevates PD-L1 levels in human cancer cells through enhancing protein stabilization accompanied with enhanced β-TrCP … L Deng, G Qian, S Zhang, H Zheng, S Fan, GB Lesinski, TK Owonikoko, ... Oncogene 38 (35), 6270-6282, 2019 | 69 | 2019 |
| Combination of anti-HER3 antibody MM-121/SAR256212 and cetuximab inhibits tumor growth in preclinical models of head and neck squamous cell carcinoma N Jiang, D Wang, Z Hu, HJC Shin, G Qian, MA Rahman, H Zhang, ... Molecular cancer therapeutics 13 (7), 1826-1836, 2014 | 69 | 2014 |
| HER3 targeting sensitizes HNSCC to cetuximab by reducing HER3 activity and HER2/HER3 dimerization: evidence from cell line and patient-derived xenograft models D Wang, G Qian, H Zhang, KR Magliocca, S Nannapaneni, ARMR Amin, ... Clinical Cancer Research 23 (3), 677-686, 2017 | 68 | 2017 |
| Aflatoxin and PAH exposure biomarkers in a US population with a high incidence of hepatocellular carcinoma NM Johnson, G Qian, L Xu, D Tietze, A Marroquin-Cardona, A Robinson, ... Science of the total environment 408 (23), 6027-6031, 2010 | 66 | 2010 |
| Sequential dietary exposure to aflatoxin B1 and fumonisin B1 in F344 rats increases liver preneoplastic changes indicative of a synergistic interaction G Qian, L Tang, S Lin, KS Xue, NJ Mitchell, J Su, WC Gelderblom, ... Food and Chemical Toxicology 95, 188-195, 2016 | 51 | 2016 |
| Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma G Qian, N Jiang, D Wang, S Newman, S Kim, Z Chen, G Garcia, ... Cancer 121 (20), 3600-3611, 2015 | 47 | 2015 |
| Genetic variations of hepatitis B virus and serum aflatoxin-lysine adduct on high risk of hepatocellular carcinoma in Southern Guangxi, China L Xu, G Qian, L Tang, J Su, JS Wang Journal of hepatology 53 (4), 671-676, 2010 | 47 | 2010 |
| Human papillomavirus 16 oncoprotein regulates the translocation of β‐catenin via the activation of epidermal growth factor receptor Z Hu, S Müller, G Qian, J Xu, S Kim, Z Chen, N Jiang, D Wang, H Zhang, ... Cancer 121 (2), 214-225, 2015 | 46 | 2015 |
| ERK inhibition effectively overcomes acquired resistance of epidermal growth factor receptor‐mutant non–small cell lung cancer cells to osimertinib Y Li, H Zang, G Qian, TK Owonikoko, SR Ramalingam, SY Sun Cancer 126 (6), 1339-1350, 2020 | 45 | 2020 |
| Integrative Toxicopathological Evaluation of Aflatoxin B1 Exposure in F344 Rats G Qian, F Wang, L Tang, ME Massey, NJ Mitchell, J Su, JH Williams, ... Toxicologic pathology 41 (8), 1093-1105, 2013 | 43 | 2013 |
| Physiologically based toxicokinetics of serum aflatoxin B1-lysine adduct in F344 rats G Qian, L Tang, F Wang, X Guo, ME Massey, JH Williams, TD Phillips, ... Toxicology 303, 147-151, 2013 | 42 | 2013 |
| Longitudinal evaluation of aflatoxin exposure in two cohorts in south-western Uganda MS Kang, P Nkurunziza, R Muwanika, G Qian, L Tang, X Song, K Xue, ... Food Additives & Contaminants: Part A 32 (8), 1322-1330, 2015 | 41 | 2015 |
| Abdominal aortic aneurysm formation with a focus on vascular smooth muscle cells G Qian, O Adeyanju, A Olajuyin, X Guo Life 12 (2), 191, 2022 | 40 | 2022 |
| Overcoming acquired resistance of epidermal growth factor receptor‐mutant non–small cell lung cancer cells to osimertinib by combining osimertinib with the histone deacetylase … H Zang, G Qian, D Zong, S Fan, TK Owonikoko, SS Ramalingam, SY Sun Cancer 126 (9), 2024-2033, 2020 | 40 | 2020 |
| HMG-CoA synthase 1 is a synthetic lethal partner of BRAFV600E in human cancers L Zhao, J Fan, S Xia, Y Pan, S Liu, G Qian, Z Qian, HB Kang, JL Arbiser, ... Journal of Biological Chemistry 292 (24), 10142-10152, 2017 | 36 | 2017 |
| PD-L1 mediates lung fibroblast to myofibroblast transition through Smad3 and β-catenin signaling pathways X Guo, C Sunil, O Adeyanju, A Parker, S Huang, M Ikebe, TA Tucker, ... Scientific Reports 12 (1), 3053, 2022 | 32 | 2022 |
Shi-Yong SunEmory University在 emory.edu 的电子邮件经过验证
